|
AU4159197A
(en)
*
|
1996-09-04 |
1998-03-26 |
Warner-Lambert Company |
Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases
|
|
KR20000057444A
(ko)
*
|
1996-12-09 |
2000-09-15 |
로즈 암스트롱, 크리스틴 에이. 트러트웨인 |
심기능부전 및 심실확장의 치료 및 예방 방법
|
|
US6399612B1
(en)
|
1997-10-06 |
2002-06-04 |
Warner-Lambert Company |
Heteroaryl butyric acids and their derivatives as inhibitors of matrix metalloproteinases
|
|
US6169103B1
(en)
|
1998-03-03 |
2001-01-02 |
Warner-Lambert |
Fluorine-substituted biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases
|
|
CN1337932A
(zh)
*
|
1998-12-30 |
2002-02-27 |
拜尔公司 |
取代的4－联芳基丁酸和5－联芳基戊酸衍生物作为治疗呼吸疾病的基质金属蛋白酶抑制剂的用途
|
|
EP1031349A1
(en)
*
|
1999-02-25 |
2000-08-30 |
Bayer Aktiengesellschaft |
Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of cerebral diseases
|
|
US7141607B1
(en)
|
2000-03-10 |
2006-11-28 |
Insite Vision Incorporated |
Methods and compositions for treating and inhibiting retinal neovascularization
|
|
WO2001070682A2
(en)
*
|
2000-03-21 |
2001-09-27 |
The Procter & Gamble Company |
Carbocyclic side chain containing metalloprotease inhibitors
|
|
WO2001070693A2
(en)
*
|
2000-03-21 |
2001-09-27 |
The Procter & Gamble Company |
Difluorobutyric acid derivatives and their use as metalloprotease inhibitors
|
|
NZ520657A
(en)
*
|
2000-03-21 |
2004-11-26 |
Procter & Gamble |
Heterocyclic side chain containing, N-substituted metalloprotease inhibitors
|
|
KR100405914B1
(ko)
*
|
2000-04-25 |
2003-11-15 |
삼성전자주식회사 |
메트릭스 메탈로프로테이나제의 저해제로서의 비페닐부티릭산 유도체
|
|
WO2001083445A1
(en)
*
|
2000-04-25 |
2001-11-08 |
Samsung Electronics Co., Ltd. |
Biphenyl butyric acid derivative as a matrix metalloproteinase inhibitor
|
|
KR100405913B1
(ko)
*
|
2000-04-25 |
2003-11-14 |
삼성전자주식회사 |
메트릭스 메탈로프로테이나제의 저해제로서의 비페닐부티릭산 유도체
|
|
DE10047118A1
(de)
*
|
2000-09-22 |
2002-04-11 |
Bayer Ag |
Verfahren zur Herstellung von Ketocarbonsäurederivaten
|
|
DE10113604A1
(de)
*
|
2001-03-20 |
2002-10-24 |
Ibfb Gmbh Privates Inst Fuer B |
Verfahren zur Spaltung des humanen Wachstumshormons GH
|
|
WO2003006006A1
(en)
*
|
2001-07-09 |
2003-01-23 |
The Regents Of The University Of California |
Use of matrix metalloproteinase inhibitors to mitigate nerve damage
|
|
CA2471099C
(en)
*
|
2001-12-20 |
2011-04-12 |
Bristol-Myers Squibb Company |
.alpha.-(n-sulphonamido)acetamide derivatives as .beta.-amyloid inhibitors
|
|
CA2490409A1
(en)
|
2002-06-28 |
2004-01-08 |
Centocor, Inc. |
Mammalian ch1 deleted mimetibodies, compositions, methods and uses
|
|
US6734579B1
(en)
*
|
2002-07-24 |
2004-05-11 |
Apple Computer, Inc. |
System and method for activating a first device from a second device
|
|
AU2003300076C1
(en)
|
2002-12-30 |
2010-03-04 |
Angiotech International Ag |
Drug delivery from rapid gelling polymer composition
|
|
GB0312654D0
(en)
|
2003-06-03 |
2003-07-09 |
Glaxo Group Ltd |
Therapeutically useful compounds
|
|
GB0314488D0
(en)
*
|
2003-06-20 |
2003-07-23 |
Glaxo Group Ltd |
Therapeutically useful compounds
|
|
CN101087597A
(zh)
*
|
2004-12-31 |
2007-12-12 |
安万特药物公司 |
某些联苯基化合物在治疗多发性硬化症(ms)中保护神经元和少突胶质细胞的用途
|
|
AP2413A
(en)
|
2005-02-22 |
2012-06-01 |
Ranbaxy Lab Ltd |
5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other disease.
|
|
US7319152B2
(en)
|
2005-09-19 |
2008-01-15 |
Wyeth |
5-Aryl-indan-1-one and analogs useful as progesterone receptor modulators
|
|
US7414142B2
(en)
|
2005-09-19 |
2008-08-19 |
Wyeth |
5-aryl-indan-1-one oximes and analogs useful as progesterone receptor modulators
|
|
JP4936512B2
(ja)
*
|
2006-02-24 |
2012-05-23 |
公立大学法人大阪府立大学 |
光解裂性環状化合物
|
|
PL2074093T3
(pl)
|
2006-08-22 |
2013-03-29 |
Sun Pharmaceutical Ind Ltd |
Sposób przygotowywania inhibitorów metaloproteinazy macierzy i chiralnego środka wspomagającego
|
|
WO2010011302A1
(en)
*
|
2008-07-22 |
2010-01-28 |
Chdi, Inc. |
Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
|
|
US8765953B2
(en)
*
|
2008-12-23 |
2014-07-01 |
Aquilus Pharmaceuticals, Inc. |
Compounds and methods for the treatment of pain and other diseases
|
|
SG176009A1
(en)
|
2009-05-28 |
2011-12-29 |
Novartis Ag |
Substituted aminopropionic derivatives as neprilysin inhibitors
|
|
JP5466759B2
(ja)
|
2009-05-28 |
2014-04-09 |
ノバルティス アーゲー |
ネプリライシン阻害剤としての置換アミノ酪酸誘導体
|
|
JO2967B1
(en)
|
2009-11-20 |
2016-03-15 |
نوفارتس ايه جي |
Acetic acid derivatives of carbamoyl methyl amino are substituted as new NEP inhibitors
|
|
KR20140072037A
(ko)
|
2011-08-30 |
2014-06-12 |
씨에이치디아이 파운데이션, 인코포레이티드 |
키뉴레닌-3-모노옥시게나제 억제제, 약학적 조성물 및 이의 사용 방법
|
|
SI2750677T1
(sl)
|
2011-08-30 |
2017-10-30 |
Chdi Foundation, Inc. |
Inhibitorji kinurenin-3-monooksigenaze, farmacevtski sestavki in postopki njihove uporabe
|
|
WO2014083229A1
(es)
|
2012-11-28 |
2014-06-05 |
Administración General De La Comunidad Autónoma De Euskadi |
Uso de inhibidores de metaloproteasas en el tratamiento de enfermedades hepáticas poliquísticas
|
|
TR201808541T4
(tr)
|
2013-02-14 |
2018-07-23 |
Novartis Ag |
Nep (nötr endopeptidaz) inhibitörleri olarak ikame edilmiş bisfenil butanoik fosfonik asit türevleri.
|
|
JP6301371B2
(ja)
|
2013-02-14 |
2018-04-11 |
ノバルティス アーゲー |
インビボ効力が改善されたｎｅｐ阻害剤としての置換ビスフェニルブタン酸誘導体
|
|
US20170022171A1
(en)
|
2014-04-03 |
2017-01-26 |
Bayer Pharma Aktiengesellschaft |
2,5-disubstituted cyclopentanecarboxylic acids and their use
|
|
US20170119776A1
(en)
|
2014-04-03 |
2017-05-04 |
Bayer Pharma Aktiengesellschaft |
Chiral 2,5-disubstituted cyclopentanecarboxylic acid derivatives and use thereof
|
|
CA2944614A1
(en)
|
2014-04-03 |
2015-10-08 |
Bayer Pharma Aktiengesellschaft |
2,5-disubstituted cyclopentane carboxylic acids for the treatment of respiratoy tract diseases
|
|
AU2015289492B2
(en)
|
2014-07-17 |
2020-02-20 |
Chdi Foundation, Inc. |
Methods and compositions for treating HIV-related disorders
|
|
FR3035105A1
(fr)
|
2015-04-16 |
2016-10-21 |
Metabrain Res |
Derives utiles dans le traitement de l'atrophie musculaire
|
|
CN109422644A
(zh)
*
|
2017-09-04 |
2019-03-05 |
任洁 |
芬布芬体内代谢产物及衍生物的用途
|
|
CN109422645A
(zh)
*
|
2017-09-04 |
2019-03-05 |
任洁 |
芬布芬体内代谢产物及衍生物作为糖尿病相关靶点调节剂的用途
|